VIRTUALMAN

VIRTUALMAN is a private Taiwan-based AI drug discovery company that provides in silico tools and services to support early-stage drug development. Its core offering is the ADDD (AI-Driven Drug Development) platform, which uses auto-feature-extraction and explainable AI models to predict ADME, toxicity, pharmacokinetic, and related preclinical properties of candidate compounds. The company also offers a web-based ADMET/PK prediction solution and customized AI model development for pharma and biotech users. Rather than developing a disclosed therapeutic pipeline of its own, VIRTUALMAN appears to operate primarily as a platform and services company focused on accelerating hit-to-lead and lead optimization workflows.